We describe a human immunodeficiency virus-infected man with relapsing rashes and reactivation of human herpesvirus-8 (HHV-8) infection, which evolved into multicentric Castleman disease. Initial skin biopsy revealed infiltrating HHV-8-positive plasmablasts, a subset of which supported lytic infection. We document the first case, to our knowledge, of HHV-8-induced rash and suggest that circulating plasmablasts drive HHV-8 to target tissues.
Human herpesvirus-8 (HHV-8) is a Gammaherpesviriniae associated with all types of Kaposi sarcoma, some forms of multicentric Castleman disease (MCD), and rare lymphoproliferative disorders. HHV-8 has a cutaneous tropism that has been well established in Kaposi sarcoma [1] . In addition, skin rashes have been reported (but not documented) during both primary HHV-8 infection and reactivation of infection [2] [3] [4] . Because, to our knowledge, rashes have not been histologically investigated, the direct role of HHV-8 in skin lesions is unknown, and the question concerning how the virus enters the skin is still debated.
MCD is a systemic disease that presents as fever, lymphadenopathy, splenomegaly, and inflammatory syndrome. HHV-8 is present in all cases of HIV-associated MCD and in 10%-50% of cases in HIV-uninfected persons. In both cases, the involvement of HHV-8 is attested by high HHV-8 loads in whole-blood specimens [5] ; HHV-8-positive plasmablasts visualized in the mantle zone of pathologic lymph nodes as large cells of a B lineage that express the latent nuclear antigen-1 (LNA-1) of HHV-8 [6] ; and lytic infection in lymph nodes as a subset of HHV-8-positive plasmablasts expressed the viral homologue of IL-6 (v-IL6) [7] .
Specific and nonspecific cutaneous lesions have been reported in patients with MCD. Specific cutaneous lesions appear as indurated nodules with histologic features of MCD in the dermis, but the presence of HHV-8 has never been demonstrated [8] [9] [10] . Nonspecific erythematous maculopapular rashes seem to be more common [11] ; however, they have not been histologically investigated, and the pathogenic role of HHV-8 is unknown.
We describe an HIV-infected patient who developed reactivation of HHV-8 infection that involved recurrent rashes. Skin biopsy revealed infiltrating HHV-8-positive plasmablasts, a subset of which supported viral replication. MCD was diagnosed 3 months later, when superficial lymph nodes became enlarged. This was the first demonstration of direct involvement of HHV-8 in the pathogenesis of rash. The results of our investigations suggest that circulating HHV-8-positive plasmablasts delivered the virus to the skin.
Case report. In December 2006, a 73-year-old heterosexual man was admitted to the hospital after a 7-day history of hectic fever (temperature, 39ЊC), asthenia, and mental confusion. One year earlier, he received a diagnosis of asymptomatic HIV infection. He did not receive antiretroviral drugs, because his CD4 + lymphocyte count was 1700 cells/mm , and his plasma HIV load was 220,000 copies/mL. Urine, sputum, and blood cultures were sterile. The findings of a cerebral MRI examination were normal. Examination of a CSF specimen obtained by lumbar puncture revealed 18 cells/mm 3 , a protein level of 0.75 g/L, and a normal glucose level. Treatment with intravenous acyclovir and amoxicillin was administrated. Four days later, the patient developed a macular rash involving the trunk and limbs. Because the findings of microbiologic evaluations of CSF specimens remained normal, amoxicillin and acyclovir were withdrawn. Symptoms and biological abnormalities resolved in 9 days.
During week 4 after presentation, initial symptoms relapsed, and the patient experienced a weight loss of 5 kg. A skin erup- tion, preceded by fever and chills, was immediately localized to the upper limbs and the trunk and did not involve any mucosa. At first, it consisted of an erythematous, maculopapular, nonpruritic exanthema, but it gradually became mildly purpuric. The lesions were not confluent and did not spread to other parts of the skin. One to 4 days later, the lesions were revealed to be benign, with progressive and complete discoloration. Desquamation and scars were not observed.
Protein electrophoresis revealed a polyclonal elevation of the g-globulin level (24.4 g/L), with 2 oligoclonal peaks in IgG-k and IgG-l levels. Elevations of ferritin and triglyceride levels were suggestive of a hemophagocytic syndrome. A bone marrow biopsy specimen was hypercellular, with polyclonal plasmocytosis, moderate myelofibrosis, mild dysmyelopoiesis, and hemophagocytic cells. Urine, blood, and bone marrow stains and cultures tested negative for fungi, acid-fast bacilli, parasites, and common bacteria. Serologic tests demonstrated past infections with Epstein-Barr virus, cytomegalovirus, and HHV-8 (with IgG to both latent and lytic antigens). The patient tested negative for cytomegalovirus viremia. Reactivation of HHV-8 infection was suspected, and HHV-8 DNA was detected in a whole-blood specimen. Thoracoabdominal CT visualized only nonsignificant lymph nodes in the mediastinal, coeliac, and mesenteric areas. Symptoms resolved spontaneously in 3 days, and combined antiretroviral therapy (lopinavir-ritonavir, emtricitabine, and lamivudine) was started.
At the end of week 8, the patient was readmitted to the hospital for a third episode of confusion and weight loss of 6 kg. The maculopapular rash recurred, as described above (figure 1). Examination of a skin biopsy specimen stained with hematoxylin-eosin stain revealed a slight perivascular mononuclear infiltrate in the superficial dermis, with a discrete intraepidermal exocytosis. At higher magnification (original magnification, ϫ40), scattered large cells with typical cytological features of plasmablasts were seen in the perivascular area. The whole-blood HHV-8 load was 594,000 copies/mg of total DNA. The plasma Epstein-Barr virus load was 5725 copies/mL. Coombs' tests, tests for antinuclear and anti-DNA antibodies, and tests for antibodies against extractable nuclear antigens yielded negative results. Symptoms gradually resolved within 1 month.
During week 13, the patient was readmitted to the hospital for a fourth episode. Newly enlarged lymph nodes were palpable in the right groin. Examination of a lymph node biopsy specimen demonstrated specific features of MCD. The mantle and interfollicular zones contained HHV-8-positive plasmablasts, and a subset expressed HHV-8 v-IL6. Foci of Kaposi sarcoma with LNA-1-positive spindle cells, which did not express the v-IL6 antigens, were adjacent to some follicles that exhibited features of MCD.
Etoposide was administrated at a dosage of 150 mg/m 2 every 14 days. Clinical remission was attained within 2 weeks. During the 6-month follow-up period, viral loads fluctuated between 11,800 and 629 copies/mg of total DNA. The patient regained his previous level of vigorous activity, with no clinical relapse. Methods and results. Paraffin-embedded blocks from skin and lymph nodes were obtained for standard hematoxylineosin staining and immunohistochemistry, as described elsewhere [6, 12] . Examination of skin biopsy specimens revealed a slight perivascular mononuclear infiltrate in the superficial dermis with discrete intraepidermal exocytosis ( figure 2A) . The cells were mainly small and medium-sized lymphocytes, with few polymorphonuclear cells. ments confirmed that plasmablasts expressing the CD79a antigen tested positive for LNA-1 ( figure 2E ), but such staining of T lymphocytes expressing the CD3 antigen (figure 2F) yielded negative results. No LNA-1-positive fusiform or endothelial cells were detected. Neither expression of Epstein-Barr virus-encoded RNA nor p24 HIV antigen (anti-Gag mAbs; Hybridolabs, Pasteur [13] ) was seen in the infiltrate.
Discussion. We describe the first documented HHV-8-induced rash in an HIV-infected patient whose HHV-8 infection reactivated and who eventually received a diagnosis of MCD. The disease presented initially as a recurrent febrile maculopapular exanthema on the trunk and the limbs. Examination of a skin biopsy specimen disclosed no cutaneous hemophagocytic syndrome and no Epstein-Barr virus-related rash. By contrast, the causative role of HHV-8 in exanthema was demonstrated by the presence of HHV-8-positive plasmablasts in the dermis, with a subset expressing the v-IL6 antigen, and the association of activated T lymphocytes. In fact, the expression of v-IL6 in the skin not only illustrates the replication of HHV-8 but also suggests that v-IL6 itself may contribute to the inflammatory skin reaction associated with exanthema.
The case of febrile exanthema in our patient exhibited clinical similarities with cases reported in persons with primary HHV-8 infection [2] , reactivation of HHV-8 infection in immunocompromised hosts [3, 4] , and persons with nonspecific MCD rash. However, additional comparisons cannot be made, because none of these patients underwent histologic investigation for HHV-8.
In the patient who we describe, reactivation of HHV-8 infection was established by week 6, but MCD was only diagnosed at week 13, when superficial nodes became enlarged and were examined. The chronology of events favors a continuous process between reactivation of HHV-8 infection and MCD, during which HHV-8-infected plasmablasts delivered the virus into the skin and triggered the skin rash. This view is reinforced by the previous observation of HHV-8-positive plasmablasts in the blood compartment of patients with MCD [14] . In our case, the association between HHV-8-positive plasmablasts (ei-ther localized in the lumen of vascular space [ figure 2F ] or the perivascular area [ figure 2B ) and the presence of an immune reaction in the perivascular area ( figure 2F ) strongly indicate that HHV-8-infected plasmablasts came from the blood compartment before seeding into the skin.
Our findings advance the hypothesis that plasmablasts act as a Trojan horse that carries the virus to the target tissues. The demonstration of HHV-8 replication in a subset of plasmablasts that infiltrated the skin and lymph nodes suggests that the virus may be released from plasmablasts and infect other types of cells in these tissues. This could contribute to the secondary development of Kaposi sarcoma, with delivery of the virus to endothelial cells of either lymphatic or vascular origin.
